GSK news
The latest GSK news, : Cerebras CEO dismisses AI doomsday warnings at TechCrunch Disrupt.
The provided stories do not state what GSK is or mention the company in any headline or digest. The recent coverage focuses on Cerebras CEO Andrew Feldman dismissing AI doomsday warnings, the SpaCEy graph neural network linking spatial tissue patterns to clinical outcomes, and JourneyTrack launching Scout AI agents to strengthen journey governance.
2 stories mentioning GSK since 26 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
Cerebras CEO dismisses AI doomsday warnings at TechCrunch Disrupt
Andrew Feldman, CEO of Cerebras Systems, criticized the growing AI doomsday narrative during his appearance at TechCrunch Disrupt 2026. He argued that public discussions often overlook AI’s potential benefits, such as…
2 sourcesTechCrunch AI -
SpaCEy links spatial tissue patterns to clinical outcomes
SpaCEy is an explainable graph neural network that models tissues as spatial graphs derived from molecular marker expression. The model does not rely on predefined cell‑type labels or anatomical regions. It captures…
1 source primary sourceNature Machine Learning
Questions about GSK
What is the latest GSK news?
As of 13 October 2026: Cerebras CEO dismisses AI doomsday warnings at TechCrunch Disrupt. Andrew Feldman, CEO of Cerebras Systems, criticized the growing AI doomsday narrative during his appearance at TechCrunch Disrupt 2026.
What is GSK?
The provided stories do not state what GSK is or mention the company in any headline or digest. The recent coverage focuses on Cerebras CEO Andrew Feldman dismissing AI doomsday warnings, the SpaCEy graph neural network linking spatial tissue patterns to clinical outcomes, and JourneyTrack launching Scout AI agents to strengthen journey governance.